eNose Predicts Immunotherapy Treatment Effectiveness

It's claimed the device achieves 85 percent accuracy in predicting which lung cancer patients will, or will not, respond to new immunotherapy treatments
It’s claimed the device achieves 85 percent accuracy in predicting which lung cancer patients will, or will not, respond to new immunotherapy treatments
Amsterdam University Medical Centers

An impressive new study is suggesting a simple breath analysis can accurately predict whether lung cancer patients will positively respond to novel immunotherapy treatments. Unlike current methods, which involve studying tissue samples, the new “eNose” device can offer diagnostic advice in less than 60 seconds. read more